Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Drugs for abuse testing devices aids in detecting presence of drug in the human body. Drugs for abuse testing devices comprises kits and devices. Drugs for abuse testing is basically performed using urine, hair, and saliva samples. Moreover, it also include blood and nail samples for testing. Urine is the specimen of choice because it contains secreted metabolites, which can be used to detect the presence of illicit drugs such as cocaine, heroin, diazepam, methamphetamine, marijuana, lorazepam, anabolic steroids. The equipment used in drug for abuse testing include immunoassay analyzers, chromatography instruments, breath analyzers, oral fluid testing devices, urine testing devices, and consumables. The key end users in drug for abuse testing market involve hospitals, laboratories, home users.

The U.K. drug for abuse testing devices market is estimated to be valued at US$ 275.7 million in 2020, and is expected to exhibit a CAGR of 5.0% during the forecast period (2020-2027).

Figure 1. U.K. Drug for Abuse Testing Devices Market Share (%), in Terms of Value, By Product Type, 2020

U.K. Drug for Abuse Testing Devices  | Coherent Market Insights

The rising incidence of drunk and drive cases and drug addiction are expected to drive the market growth during the forecast period.

The increasing incidence of drunk and drive cases, and drug addiction is expected to drive the U.K. drug for abuse testing devices market growth over the forecast period. For instance, according to the National Health Service U.K. report, in 2017, there were around 15,074 hospital admissions with a primary diagnosis of poisoning by illicit drugs in England.

Figure 2. U.K. Drug for Abuse Testing Devices Market Share (%), by End User, 2020

U.K. Drug for Abuse Testing Devices  | Coherent Market Insights

Increasing product launch and approval is expected to drive the U.K. for drug abuse tesing devices market growth during the forecast period.

Increasing product launches and approvals expected to boost the market growth during the forecast period. For instance, In September 2018, Securetec Detektions-Systeme AG launched new WipeAlyser, a mobile analyzer for use with the proven DrugWipe drug rapid test. Furthermore, in 2016, Securetec Detektions-Systeme AG launched updated version of DrugWipe 5 S. The company shortened the test duration to 5 minutes while increasing the sensitivity of the DrugWipe 5 S saliva test for cannabis.

request-sample

U.K. Drug for Abuse Testing Devices Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 275.7 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.0% 2027 Value Projection: US$ 389.1Mn
Geographies covered:
  • Europe: U.K.
Segments covered:
  • By Product Type:
    • Immunoassay Analyzers 
    • Chromatography Instruments
    • Breathalyzers: Semiconductor-based Breathalyzer, Infrared (IR) Based Breathalyzer, Fuel Cell-based Breathalyzer
    • Oral Fluid Testing Devices Drug Testing Cassettes
    • Urine Testing Devices: Drug Testing Cups, DIP Cards, Drug Testing Cassettes
    • Consumables: Assay Kits, Calibrators and Controls, Others
  • By Sample Type: Urine, Breathe, Saliva, Hair, Others
  • By End User: Hospitals, Federal Departments, Rehabilitation Centers, Diagnostic Laboratories, Academic Institutes and Research Centers, Others
Companies covered:

Abbott Laboratories, Thermo Fisher Scientific, Inc, Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics, Alfa Scientific Designs, Inc, Lifeloc Technologies Inc, Lion Laboratories Limited, OraSure Technologies, Inc, Omega Laboratories, Inc., Shimadzu Corporation, Siemens Healthineers, F. Hoffmann-La Roche AG, Premier Biotech, Inc, Psychemedics Corporation, Innovative Testing Solutions, Biopanda Reagents Ltd, Alpha Laboratories, Matrix Diagnostics, Atlas Medical, Rapid Labs Limited, and Randox Laboratories Ltd.

Growth Drivers:
  • Rising incidence of drunk and drive cases and drug addiction
  • Increasing government initiatives to reduce the incidence of driving under influence of drugs and alcohol
Restraints & Challenges:
  • Inaccurate and false results by breath analyzers and testing devices 
  • Availability of low cost alcohol Breathalyzer and drug testing devices manufactured by local players

U.K. Drug for Abuse Testing Devices Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries, across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of Coronavirus (COVID-19) has resulted in over 153 million infected individuals worldwide, as of May 4, 2021.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drugs from one place to another.

Furthermore, players operating in the U.K. drug for abuse testing devices market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials required for manufacturing of testing devices due to irregularities in transportation.

U.K. Drug for Abuse Testing Devices Market: Restraint

The major factors that are expected to hinder growth of the U.K. drug for abuse testing devices market include availability of low cost alcohol Breathalyzer and drug testing devices manufactured by local players and inaccurate & false results by breath analyzers and testing devices.

Key Players

Major players operating in the U.K. drug for abuse testing devices market include Abbott Laboratories, Thermo Fisher Scientific, Inc, Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics, Alfa Scientific Designs, Inc, Lifeloc Technologies Inc, Lion Laboratories Limited, OraSure Technologies, Inc, Omega Laboratories, Inc., Shimadzu Corporation, Siemens Healthineers, F. Hoffmann-La Roche AG, Premier Biotech, Inc, Psychemedics Corporation, Innovative Testing Solutions, Biopanda Reagents Ltd, Alpha Laboratories, Matrix Diagnostics, Atlas Medical, Rapid Labs Limited, and Randox Laboratories Ltd.

Drug for abuse are illegal drugs consumed for the non-medication purpose for longer period of time. Drugs of abuse testing is performed both for medical purposes and legal causes such as workplace drug testing. The test for drug for abuse include immunoassay to screen different samples and the confirmation of screening results by definitive analytical techniques such as spectrometry and chromatography. Illicit drugs include cocaine, amphetamines, heroin, and hallucinogens are substances that can inhibit the central nervous system and cause hallucinogenic effects. The key end users in drug for abuse testing market include hospitals, diagnostic laboratories, federal departments, and rehabilitation centers. Some of the other end users are academic institutes and research laboratories.

Market Dynamics

The increasing production and trade of illicit drugs, rise in road accidents and death rates, increase in the consumption of illegal drugs, and growing government initiatives to reduce the incidence of driving under influence of drugs and alcohol are the factors that are driving growth of the market. For instance, according to data by the National Health Services, the number of hospital admissions in England for heroin or other opioid poisoning increased by 121%, since the past 12 years (2006-2018). The number of patients were around 7,258 in the year 2017-2018. Furthermore, According to the press release by Gov. UK in July 2017, the Home Secretary has launched the government’s new drug strategy, to reduce illicit drug use and increase the rate of individuals recovering from drug dependence. The new strategy confronts these threats and sets out new action to protect the most vulnerable, including the homeless, victims of domestic abuse and those with mental health issues.

Key features of the study:

  • This report provides in-depth analysis of the U.K. drug for abuse testing device market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.K. drug for abuse testing device market based on the following parameters – Company Highlights, Product Types Portfolio, Key Highlights, Financial Performance, and Market Strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Inc, Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics, Alfa Scientific Designs, Inc, Lifeloc Technologies Inc, Lion Laboratories Limited, OraSure Technologies, Inc, Omega Laboratories, Inc., Shimadzu Corporation, Siemens Healthineers, F. Hoffmann-La Roche AG, Premier Biotech, Inc, Psychemedics Corporation, Innovative Testing Solutions, Biopanda Reagents Ltd, Alpha Laboratories, Matrix Diagnostics, Atlas Medical, Rapid Labs Limited, and Randox Laboratories Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The U.K. drug for abuse testing device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.K. drug for abuse testing device market

Detailed Segmentation:

  • U.K. Drug for Abuse Testing Device Market, By Product Type:
    • Immunoassay Analyzers
    • Chromatography Instruments
    • Breathalyzers
      • Semiconductor-based Breathalyzer
      • Infrared (IR) Based Breathalyzer
      • Fuel Cell-based Breathalyzer
    • Oral Fluid Testing Devices
    • Urine Testing Devices
      • Drug Testing Cups
      • DIP Cards
      • Drug Testing Cassettes
    • Consumables
      • Assay Kits
      • Calibrators and Controls
      • Others
  • U.K. Drug for Abuse Testing Device Market, By Sample Type:
    • Urine
    • Breathe
    • Saliva
    • Hair
    • Others
  • U.K. Drug for Abuse Testing Device Market, By End user:
    • Hospitals
    • Federal Departments
    • Rehabilitation Centers
    • Diagnostic Laboratories
    • Academic Institutes and Research Centers
    • Others
  • Company Profiles
    • Abbott Laboratories*
      • Company Highlights
      • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific, Inc
    • Drägerwerk AG & Co. KGaA
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics
    • Alfa Scientific Designs, Inc
    • Lifeloc Technologies Inc.
    • Lion Laboratories Limited
    • OraSure Technologies, Inc.
    • Omega Laboratories, Inc.
    • Shimadzu Corporation
    • Siemens Healthineers
    • F. Hoffmann-La Roche AG
    • Premier Biotech, Inc.
    • Psychemedics Corporation
    • Innovative Testing Solutions
    • Biopanda Reagents Ltd
    • Alpha Laboratories
    • Matrix Diagnostics
    • Atlas Medical
    • Rapid Labs Limited
    • Randox Laboratories Ltd

* marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Sample Type
      • Market Snapshot, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • PORTER’S Five Forces Analysis
    • Technological Advancements
    • Product Launch/ Approvals
    • Merger-Acquisition Scenario
    • PEST Analysis
    • Regulatory Scenario
    • Market Trends
    • Market Breakthrough Products
    • Pricing Analysis
    • Innovative Technologies for Fake Urine Detection
  4. U.K. Drug For Abuse Testing Devices Market– Impact of Coronavirus (COVID-19) Pandemic
    • Impact of COVID-19 On Drug For Abuse Testing Devices Market
    • COVID-19 Epidemiology
  5. U.K. Drug For Abuse Testing Devices Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Overview
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Immunoassay Analyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Chromatography Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Breathalyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Semiconductor-based Breathalyzer
      • Infrared (IR) Based Breathalyzer
      • Fuel Cell-based Breathalyzer
    • Oral Fluid Testing Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Urine Testing Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Drug Testing Cups
        • DIP Cards
        • Drug Testing Cassettes
    • Consumables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Assay Kits
        • Calibrators and Controls
        • Others
  6. U.K. Drug For Abuse Testing Devices Market, By Sample Type, 2016 – 2027, (US$ Mn)
    • Overview
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Urine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Breathe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Saliva
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hair
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. U.K Drug For Abuse Testing Device Market, By End User, 2016 – 2027, (US$ Mn)
    • Overview
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Federal Departments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Rehabilitation Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Academic Institutes and Research Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Competitive Landscape
    • Heat Map Analysis
    • U.K. Company Share Analysis, 2019
      • Abbott Laboratories
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Thermo Fisher Scientific, Inc.
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Drägerwerk AG & Co. KGaA
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Laboratory Corporation of America Holdings
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Quest Diagnostics
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Alfa Scientific Designs, Inc
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Lifeloc Technologies Inc.
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Lion Laboratories Limited
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • OraSure Technologies, Inc.
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Omega Laboratories, Inc.
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Shimadzu Corporation
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Siemens Healthineers
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hoffmann-La Roche AG
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Premier Biotech, Inc..
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Psychemedics Corporation
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Innovative Testing Solutions
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Biopanda Reagents Ltd
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Alpha Laboratories
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Matrix Diagnostics
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Atlas Medical
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Rapid Labs Limited
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Randox Laboratories Ltd.
        • Company Highlights
        • Product Types Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
    • Analyst Views
  9. Section
    • Research Methodology
    • About us

*Browse 9 market data tables and 26 figures on "U.K. Drug for Abuse Testing Devices Market” - Global forecast to 2027

FAQgrowicon

Frequently Asked Questions

The U.K. drug for abuse testing devices market size is estimated to be valued at US$ 275.7 million in 2020 and is expected to exhibit a CAGR of 5.0% between 2020 and 2027.
Factors such as rising incidence of drunk and drive cases & drug addiction and increasing government initiatives to reduce the incidence of driving under influence of drugs and alcohol are expected to drive the market growth during the forecast period.
Consumable segment is expected to hold a major market share during the forecast period.
The major factors hampering growth of the market include inaccurate and false results by breath analyzers and testing devices and availability of low cost alcohol Breathalyzer and drug testing devices manufactured by local players.
Major players operating in the market include Abbott Laboratories, Thermo Fisher Scientific, Inc, Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics, Alfa Scientific Designs, Inc, Lifeloc Technologies Inc, Lion Laboratories Limited, OraSure Technologies, Inc, Omega Laboratories, Inc., Shimadzu Corporation, Siemens Healthineers, F. Hoffmann-La Roche AG, Premier Biotech, Inc, Psychemedics Corporation, Innovative Testing Solutions, Biopanda Reagents Ltd, Alpha Laboratories, Matrix Diagnostics, Atlas Medical, Rapid Labs Limited, and Randox Laboratories Ltd.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner